Summary
Machine-generated summaryParticipating German statutory health insurance funds, including TK, seek discount agreements under § 130c para. 1 SGB V for the active substance Alectinib, originator medicines. The procedure is an Open-House process: no individual negotiations take place, uniform conditions apply to all suitable pharmaceutical entrepreneurs, and no exclusivity is granted. The contract runs a maximum of 24 months from 1 August 2026 and ends no later than 31 July 2028; it terminates automatically if patent or market exclusivity expires earlier. Joining is possible at any time during the contract term. No estimated value is stated. Details are in the participation and contract documents.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile52 open tenders right now
- Medicines - Open-House discount contracts 2026-06 - Safinamide 218 days left
- Medicines - Open-House Biosimilar Discount Agreements 2026-03a - Eculizumab (excluding the gMG and NMOSD indications) 341 days left
- Medicines - Open-House Biosimilar Discount Agreements 2026-03b - Eculizumab (including the indications gMG and NMOSD) 341 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Siemens Healthineers AG | 41 | €17.4M | Aug 2026 |
| Philips GmbH | 20 | €5.3M | Sep 2026 |
| GlaxoSmithKline GmbH & Co. KG | 15 | n/a | Sep 2026 |
| ASTRAZENECA GMBH | 12 | n/a | Jul 2026 |
| Brainlab Sales GmbH | 10 | €4.0M | Sep 2026 |
Based on 1011 awards with a linked company profile over the last 2 years.
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Act now
- Submission deadline: Moved 1 day EARLIER: now July 31, 2028, 00:00
- Scope and criteria: The description was expanded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,211,630
- Buyer track record on Aperlena
- 54 notices tracked · 0 awarded
Never miss a tender like this
69 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert